Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial
Marcia S. Brose, Bruce G. Robinson, Steven I. Sherman, Barbara Jarząb, Chia‐Chi Lin, Fernanda Vaisman and 8 more
- Rank
- 15 of 442
- Percentile
- top 3.4%
- Where
- Cancer, 2022
- Citations
- 76
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.